Renub

    United States Home Infusion Market, Size, Share, Forecast 2024-2030, Industry Trends, Growth, Insight, Top Companies Analysis

    Excel: 12 Hours
    PDF: 24 Hours
    Nov 2022
    Pages: 150

    United States Home Infusion Market Outlook

    United States Home Infusion Market will reach US$ 20.6 Billion by 2027 according to Renub Research. Home infusion is a clinically suitable treatment option for patients with a wide array of chronic and acute conditions, ranging from bacterial infections to progressively complex conditions like immune deficiencies, nutrition support, bleeding disorders, and late-stage heart failure. Home infusion can afford patients liberty and better quality of life since it is offered in the comfort of the patient's home, effectively fitting their needs. It also gives better outcomes, provides enhanced safety, and is cost-effective.

     

    united-states-home-infusion-therapy-market


    The increasing geriatric population susceptible to chronic diseases and rising prevalence of urinary tract infections will boost the market growth:

    The rapidly growing old-aged population in the United States is one of the main drivers of market growth. For instance, according to data issued by the United States Department of Health and Human Services, there are more than 49.2 million individuals above 65 years of age across the country. Moreover, the number of graying Americans has risen by around 33% over the past decennium. Therefore, as home infusion therapy aids in managing chronic conditions of the elderly populace, the market will witness significant growth in the future.


    According to a recent news article, urinary tract infections contribute to about 6 million patient visits to physicians each year in the United States Thus, a large patient pool requiring home infusion therapy will generate high demand over the analyzed period. In addition, the acceptance of new technologies in the home infusion therapy market will support the industry's growth.


    United States Home Infusion Market is expected to grow with a CAGR of 7.88% from 2022 to 2027

    Amongst other segments, an infusion pump holds a significant share in 2022. This can be attributed to their efficiency and increasing use in delivering medications, nutrition, and other required fluids in required amounts. Needleless connectors is anticipated to be the fastest-growing segment over the forecast period owing to various benefits, such as higher protection against needlestick injuries and less risk of bacterial contamination. In addition, needleless connectors reduce the risk of Healthcare Associated Bloodstream Infections. Owing to these features, the demand for needleless connectors is predicted to augment over the forecast period.


    Indication Insights:

    Based on Indication, the U.S. home infusion therapy market is categorized into Anti-infective, Chemotherapy, Hydration Therapy, Enteral Nutrition, Parenteral Nutrition, Immunoglobulins, and Others. Hydration therapy provides several benefits, such as boosting immunity and reduced recovery time. It also improves cognitive functions, flushes toxins from the body, is efficient, it tends to strengthen joint, skin, and muscle health.


    COVID-19 Impact on U.S. Home Infusion Therapy Market:

    The COVID-19 pandemic has positively impacted the Industry. The U.S. Key players reported a significant growth in revenues from services, devices, and drugs, owing to the considerable increase in patients receiving infusion therapy at home during COVID-19 restrictions. For instance, Option Care Health, Inc. generated USD 3,302.6 million in 2020 and witnessed a 30.1% increase in its revenue in 2020 compared to 2019. The growth was attributable to increased demand for its home infusion therapy services. 


    Furthermore, In October 2020, the Centers for Medicare & Medicaid Services (CMS) announced a proposed rule broadening coverage for home infusion Durable Medical Equipment (DME), specifically for external infusion pumps, to increase access to home infusion drugs. Moreover, with the COVID-19 outbreak, home-infusion solutions have become more critical than ever, allowing patients to remain in their homes, thereby decreasing the risk of exposure. Hence, various local infusion service providers witnessed a surge in demand for home-based services.


    Key Players:

    CVS Health, Becton, Dickinson and Company, Smith & Nephew plc, Terumo Corporation, ICU Medical, Moog, and InfuSystems Holdings are the leading competitors in the U.S. home infusion therapy market. Further, these organizations employ various techniques to drive their company portfolio worldwide, including innovative product releases and R&D.


    Renub Research latest report “U.S. Home Infusion Therapy Market, Forecast By Product (Home Infusion Device, Home Infusion Drugs, Home Infusion Services), Product Type (Infusion Pump, Intravenous Sets, IV Cannulas, Needleless Connectors), Indication (Anti-infective, Chemotherapy, HydrationTherapy, EnteralNutrition, Parenteral Nutrition, Immunoglobulins, Others), Zone ( East North Central, West South Central, South Atlantica, North East,  East South Central, West North Centre, Pacific Central, Mountain States,) Companies (CVS Health, Becton, Dickinson and Company, Smith & Nephew plc, Terumo Corporation, ICU Medical, Moog, InfuSystems Holdings)” provides a detailed analysis of U.S. Home Infusion Therapy Industry.

     

    united-states-home-infusion-therapy-market-share


    Product – The market has been studied from 3 viewpoints:

    1.    Home Infusion Device
    2.    Home Infusion Drugs
    3.    Home Infusion Services


    Product Type – The market has been studied from 4 viewpoints:

    1.    Infusion Pump
    2.    Intravenous Sets
    3.    IV Cannulas
    4.    Needleless Connectors


    Indication – The market has been studied from 7 viewpoints:

    1.    Anti-infective
    2.    Chemotherapy
    3.    Hydration Therapy
    4.    Enteral Nutrition
    5.    Parenteral Nutrition
    6.    Immunoglobulins
    7.    Others


    Zone – The market has been studied from 8 viewpoints:

    1.    East North Central
    2.    West South Central
    3.    South Atlantica
    4.    North East
    5.    East South Central
    6.    West North Centre
    7.    Pacific Central
    8.    Mountain States


    Company Insights:

    •    Overview
    •    Initiatives/Recent Developments
    •    Financial Insight


    Companies Covered:

    1.    CVS Health
    2.    Becton, Dickinson and Company
    3.    Smith & Nephew plc
    4.    Terumo Corporation
    5.    ICU Medical
    6.    Moog
    7.    InfuSystems Holdings


    Report Details:

    Report Features Details
    Base Year 2022
    Historical Period 2017 - 2022
    Forecast Period 2023 - 2027
    Market US$ Billion
    Segment Covered Product, Product Type, Indication, and Zone
    Zone Covered East North Central, West South Central, South Atlantica, North East, East South Central, West North Centre, Pacific Central, and Mountain States
    Companies Covered CVS Health, Becton, Dickinson and Company, Smith & Nephew plc, Terumo Corporation, ICU Medical, Moog, and InfuSystems Holdings
    Customization Scope 20% Free Customization
    Post-Sale Analyst Support 1 Year (52 Weeks)
    Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)


    FREQUENTLY ASKED QUESTIONS:

    •    What is the market value of U.S. home infusion therapy industry?
    •    What is the U.S. home infusion therapy market growth?
    •    Which segment accounted for the largest United states home infusion therapy market share?
    •    Who are the key players in the U.S. home infusion therapy market?

    1.    Introduction

    2.    Research & Methodology

    3.    Executive Summary

    4.    Market Dynamics

    4.1    Growth Drivers
    4.2    Challenges


    5.    United States Home Infusion Therapy Market

    6.    Market Share – United States Home Infusion Therapy Market

    6.1    By Product
    6.2    By Product Type
    6.3    By Indication
    6.4    By Zone


    7.    Product – United States Home Infusion Therapy Market

    7.1    Home Infusion Device
    7.2    Home Infusion Drugs
    7.3    Home Infusion Services


    8.    Product Type – United States Home Infusion Therapy Market

    8.1    Infusion Pump
    8.2    Intravenous Sets
    8.3    IV Cannulas
    8.4    Needleless Connectors


    9.    Indication – United States Home Infusion Therapy Market

    9.1    Anti-infective
    9.2    Chemotherapy
    9.3    Hydration Therapy
    9.4    Enteral Nutrition
    9.5    Parenteral Nutrition
    9.6    Immunoglobulins
    9.7    Others


    10.    Zone – United States Home Infusion Therapy Market

    10.1    East North Central
    10.2    West South Central
    10.3    South Atlantica
    10.4    North East
    10.5    East South Central
    10.6    West North Centre
    10.7    Pacific Central
    10.8    Mountain States


    11.    Key Players

    11.1    CVS Health

    11.1.1    Overview
    11.1.2    Recent Development
    11.1.3    Revenue

    11.2    Becton, Dickinson and Company

    11.2.1    Overview
    11.2.2    Recent Development
    11.2.3    Revenue

    11.3    Smith & Nephew plc

    11.3.1    Overview
    11.3.2    Recent Development
    11.3.3    Revenue

    11.4    Terumo Corporation

    11.4.1    Overview
    11.4.2    Recent Development
    11.4.3    Revenue

    11.5    ICU Medical

    11.5.1    Overview
    11.5.2    Recent Development
    11.5.3    Revenue

    11.6    Moog

    11.6.1    Overview
    11.6.2    Recent Development
    11.6.3    Revenue

    11.7    InfuSystems Holdings

    11.7.1    Overview
    11.7.2    Recent Development
    11.7.3    Revenue


    List of Figures:

    Figure-01:    United States – Home Infusion Therapy Market (Million US$), 2017 – 2022
    Figure-02:    United States – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
    Figure-03:    Product – Home Infusion Device Market (Million US$), 2017 – 2022
    Figure-04:    Product – Forecast for Home Infusion Device Market (Million US$), 2023 – 2027
    Figure-05:    Product – Home Infusion Drugs Market (Million US$), 2017 – 2022
    Figure-06:    Product – Forecast for Home Infusion Drugs Market (Million US$), 2023 – 2027
    Figure-07:    Product – Home Infusion Services Market (Million US$), 2017 – 2022
    Figure-08:    Product – Forecast for Home Infusion Services Market (Million US$), 2023 – 2027
    Figure-09:    Product Type – Infusion Pump Market (Million US$), 2017 – 2022
    Figure-10:    Product Type – Forecast for Infusion Pump Market (Million US$), 2023 – 2027
    Figure-11:    Product Type – Intravenous Sets Market (Million US$), 2017 – 2022
    Figure-12:    Product Type – Forecast for Intravenous Sets Market (Million US$), 2023 – 2027
    Figure-13:    Product Type – IV Cannulas Market (Million US$), 2017 – 2022
    Figure-14:    Product Type – Forecast for IV Cannulas Market (Million US$), 2023 – 2027
    Figure-15:    Product Type – Needleless Connectors Market (Million US$), 2017 – 2022
    Figure-16:    Product Type – Forecast for Needleless Connectors Market (Million US$), 2023 – 2027
    Figure-17:    Indication – Anti-infective Market (Million US$), 2017 – 2022
    Figure-18:    Indication – Forecast for Anti-infective Market (Million US$), 2023 – 2027
    Figure-19:    Indication – Chemotherapy Market (Million US$), 2017 – 2022
    Figure-20:    Indication – Forecast for Chemotherapy Market (Million US$), 2023 – 2027
    Figure-21:    Indication – Hydration Therapy Market (Million US$), 2017 – 2022
    Figure-22:    Indication – Forecast for Hydration Therapy Market (Million US$), 2023 – 2027
    Figure-23:    Indication – Enteral Nutrition Market (Million US$), 2017 – 2022
    Figure-24:    Indication – Forecast for Enteral Nutrition Market (Million US$), 2023 – 2027
    Figure-25:    Indication – Parenteral Nutrition Market (Million US$), 2017 – 2022
    Figure-26:    Indication – Forecast for Parenteral Nutrition Market (Million US$), 2023 – 2027
    Figure-27:    Indication – Immunoglobulins Market (Million US$), 2017 – 2022
    Figure-28:    Indication – Forecast for Immunoglobulins Market (Million US$), 2023 – 2027
    Figure-29:    Indication – Others Market (Million US$), 2017 – 2022
    Figure-30:    Indication – Forecast for Others Market (Million US$), 2023 – 2027
    Figure-31:    East North Central – Home Infusion Therapy Market (Million US$), 2017 – 2022
    Figure-32:    East North Central – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
    Figure-33:    West South Central – Home Infusion Therapy Market (Million US$), 2017 – 2022
    Figure-34:    West South Central – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
    Figure-35:    South Atlantica – Home Infusion Therapy Market (Million US$), 2017 – 2022
    Figure-36:    South Atlantica – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
    Figure-37:    North East – Home Infusion Therapy Market (Million US$), 2017 – 2022
    Figure-38:    North East – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
    Figure-39:    East South Central – Home Infusion Therapy Market (Million US$), 2017 – 2022
    Figure-40:    East South Central – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
    Figure-41:    West North Centre – Home Infusion Therapy Market (Million US$), 2017 – 2022
    Figure-42:    West North Centre – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
    Figure-43:    Pacific Central – Home Infusion Therapy Market (Million US$), 2017 – 2022
    Figure-44:    Pacific Central – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
    Figure-45:    Mountain States – Home Infusion Therapy Market (Million US$), 2017 – 2022
    Figure-46:    Mountain States – Forecast for Home Infusion Therapy Market (Million US$), 2023 – 2027
    Figure-47:    CVS Health – Global Revenue (Million US$), 2017 – 2022
    Figure-48:    CVS Health – Forecast for Global Revenue (Million US$), 2023 – 2027
    Figure-49:    Becton, Dickinson and Company – Global Revenue (Million US$), 2017 – 2022
    Figure-50:    Becton, Dickinson and Company – Forecast for Global Revenue (Million US$), 2023 – 2027
    Figure-51:    Smith & Nephew plc – Global Revenue (Million US$), 2017 – 2022
    Figure-52:    Smith & Nephew plc – Forecast for Global Revenue (Million US$), 2023 – 2027
    Figure-53:    Terumo Corporation – Global Revenue (Million US$), 2017 – 2022
    Figure-54:    Terumo Corporation – Forecast for Global Revenue (Million US$), 2023 – 2027
    Figure-55:    ICU Medical – Global Revenue (Million US$), 2017 – 2022
    Figure-56:    ICU Medical – Forecast for Global Revenue (Million US$), 2023 – 2027
    Figure-57:    Moog – Global Revenue (Million US$), 2017 – 2022
    Figure-58:    Moog – Forecast for Global Revenue (Million US$), 2023 – 2027
    Figure-59:    InfuSystems Holdings – Global Revenue (Million US$), 2017 – 2022
    Figure-60:    InfuSystems Holdings – Forecast for Global Revenue (Million US$), 2023 – 2027


    List of Tables:

    Table-01:    United States – Home Infusion Therapy Market Share by  Product (Percent), 2017 – 2022
    Table-02:    United States – Forecast for Home Infusion Therapy Market Share by Product (Percent), 2023 – 2027
    Table-03:    United States – Home Infusion Therapy Market Share by Product Type (Percent), 2017 – 2022
    Table-04:    United States – Forecast for Home Infusion Therapy Market Share by Product Type (Percent), 2023 – 2027
    Table-05:    United States – Home Infusion Therapy Market Share by Indication (Percent), 2017 – 2022
    Table-06:    United States – Forecast for Home Infusion Therapy Market Share by Indication (Percent), 2023 – 2027
    Table-07:    United States – Home Infusion Therapy Market Share by Zone (Percent), 2017 – 2022
    Table-08:    United States – Forecast for Home Infusion Therapy Market Share by Zone (Percent), 2023 – 2027

    • Description
      Price
    • Chapter 7     Pages : 10
      $500
    • Chapter 8     Pages : 14
      $600
    • Chapter 9     Pages : 22
      $800
    • Chapter 10     Pages : 25
      $800
    • Chapter 11.1     Pages : 5
      $150
    • Chapter 11.2     Pages : 5
      $150
    • Chapter 11.3     Pages : 5
      $150
    • Chapter 11.4     Pages : 5
      $150
    • Chapter 11.5     Pages : 5
      $150
    • Chapter 11.6     Pages : 5
      $150
    • Chapter 11.7     Pages : 5
      $150

    Related Reports